| NQO | Name: | 2-(3-chlorophenyl)-N-(4-methylpyridazin-3-yl)acetamide | Formula: | C13 H12 Cl N3 O | SMILES: | Cc1ccnnc1NC(=O)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C13H12ClN3O/c1-9-5-6-15-17-13(9)16-12(18)8-10-3-2-4-11(14)7-10/h2-7H,8H2,1H3,(H,16,17,18) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(4-methylpyridazin-3-yl)acetamide |
|
| NR0 | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-2-(6-amino-9H-purin-9-yl)-N-(2-oxoethyl)acetamide | Formula: | C13 H17 N7 O4 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)Cn1cnc2c(N)ncnc21 | InChi: | InChI=1S/C13H17N7O4/c14-7-3-24-4-8(7)20(2-10(22)23)9(21)1-19-6-18-11-12(15)16-5-17-13(11)19/h5-8H,1-4,14H2,(H,22,23)(H2,15,16,17)/t7-,8-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
| NRC | Name: | methyl (2R)-2-(3-chlorophenyl)-3-[(4-methylpyridin-3-yl)amino]-3-oxopropanoate | Formula: | C16 H15 Cl N2 O3 | SMILES: | O=C(Nc1cnccc1C)C(c1cccc(Cl)c1)C(=O)OC | InChi: | InChI=1S/C16H15ClN2O3/c1-10-6-7-18-9-13(10)19-15(20)14(16(21)22-2)11-4-3-5-12(17)8-11/h3-9,14H,1-2H3,(H,19,20)/t14-/m1/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | methyl (2R)-2-(3-chlorophenyl)-3-[(4-methylpyridin-3-yl)amino]-3-oxopropanoate |
|
| NRG | Name: | N-OMEGA-NITRO-L-ARGININE | Formula: | C6 H13 N5 O4 | SMILES: | [O-][N+](=O)NC(=[N@H])NCCCC(C(=O)O)N | InChi: | InChI=1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1 | Synonyms: | NNA | Definition date: | 1999-07-28 | Last modified: | 2023-11-03 | Identifier: | N~5~-(N-nitrocarbamimidoyl)-L-ornithine |
|
| NRL | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C12 H17 N5 O5 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)CN1C=CC(N)=NC1=O | InChi: | InChI=1S/C12H17N5O5/c13-7-5-22-6-8(7)17(4-11(19)20)10(18)3-16-2-1-9(14)15-12(16)21/h1-2,7-8H,3-6,13H2,(H,19,20)(H2,14,15,21)/t7-,8-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]glycine |
|
| NRP | Name: | {4-[(4-hydroxyphenyl)methylidene]-2-[(1E)-3-methylbutanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C17 H19 N3 O4 | SMILES: | O=C1C(N=C(C(=[N@H])CC(C)C)N1CC(=O)O)=C/c2ccc(O)cc2 | InChi: | InChI=1S/C17H19N3O4/c1-10(2)7-13(18)16-19-14(17(24)20(16)9-15(22)23)8-11-3-5-12(21)6-4-11/h3-6,8,10,18,21H,7,9H2,1-2H3,(H,22,23)/b14-8+,18-13+ | Synonyms: | CHROMOPHORE (LEU-TYR-GLY) | Definition date: | 2010-04-07 | Last modified: | 2023-11-03 | Identifier: | {(4E)-4-(4-hydroxybenzylidene)-2-[(1E)-3-methylbutanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| NRQ | Name: | {(4Z)-4-(4-hydroxybenzylidene)-2-[3-(methylthio)propanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C16 H17 N3 O4 S | SMILES: | O=C1C(N=C(C(=[N@H])CCSC)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C16H17N3O4S/c1-24-7-6-12(17)15-18-13(16(23)19(15)9-14(21)22)8-10-2-4-11(20)5-3-10/h2-5,8,17,20H,6-7,9H2,1H3,(H,21,22)/b13-8-,17-12- | Synonyms: | CHROMOPHORE (MET-TYR-GLY) | Definition date: | 2003-10-07 | Last modified: | 2023-11-03 | Identifier: | {(4Z)-4-[(4-hydroxyphenyl)methylidene]-2-[(1Z)-3-(methylsulfanyl)propanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| NRX | Name: | 2-(3-chlorophenyl)-N-[(4S)-imidazo[1,5-a]pyridin-1-yl]acetamide | Formula: | C15 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1ncn2ccccc12 | InChi: | InChI=1S/C15H12ClN3O/c16-12-5-3-4-11(8-12)9-14(20)18-15-13-6-1-2-7-19(13)10-17-15/h1-8,10H,9H2,(H,18,20) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-[(4S)-imidazo[1,5-a]pyridin-1-yl]acetamide |
|
| NSF | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C12 H15 I N4 O6 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)CN1C=C(I)C(=O)NC1=O | InChi: | InChI=1S/C12H15IN4O6/c13-6-1-16(12(22)15-11(6)21)2-9(18)17(3-10(19)20)8-5-23-4-7(8)14/h1,7-8H,2-5,14H2,(H,19,20)(H,15,21,22)/t7-,8-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
| 175 | Name: | 3,5-DIHYDRO-5-METHYLIDENE-4H-IMIDAZOL-4-ON | Formula: | C8 H16 N4 O3 | SMILES: | O=C1N(CC(=O)O)C(NC1CN)C(N)C | InChi: | InChI=1S/C8H16N4O3/c1-4(10)7-11-5(2-9)8(15)12(7)3-6(13)14/h4-5,7,11H,2-3,9-10H2,1H3,(H,13,14)/t4-,5-,7-/m0/s1 | Definition date: | 2004-05-23 | Last modified: | 2023-11-03 | Identifier: | [(2S,4S)-2-[(1S)-1-aminoethyl]-4-(aminomethyl)-5-oxoimidazolidin-1-yl]acetic acid |
|
| NSR | Name: | (4R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C19 H15 Cl N2 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C19H15ClN2O2/c20-13-5-6-18-16(9-13)15(7-8-24-18)19(23)22-17-11-21-10-12-3-1-2-4-14(12)17/h1-6,9-11,15H,7-8H2,(H,22,23)/t15-/m1/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| NSU | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C13 H18 N4 O6 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)CN1C=C(C)C(=O)NC1=O | InChi: | InChI=1S/C13H18N4O6/c1-7-2-16(13(22)15-12(7)21)3-10(18)17(4-11(19)20)9-6-23-5-8(9)14/h2,8-9H,3-6,14H2,1H3,(H,19,20)(H,15,21,22)/t8-,9-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
| NTA | Name: | NITRILOTRIACETIC ACID | Formula: | C6 H9 N O6 | SMILES: | O=C(O)CN(CC(=O)O)CC(=O)O | InChi: | InChI=1S/C6H9NO6/c8-4(9)1-7(2-5(10)11)3-6(12)13/h1-3H2,(H,8,9)(H,10,11)(H,12,13) | Definition date: | 1999-09-02 | Last modified: | 2023-11-03 | Identifier: | 2,2',2''-nitrilotriacetic acid |
|
| NU0 | Name: | 2-(3-chlorophenyl)-N-(2,6-naphthyridin-4-yl)acetamide | Formula: | C16 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2ccncc21 | InChi: | InChI=1S/C16H12ClN3O/c17-13-3-1-2-11(6-13)7-16(21)20-15-10-19-8-12-4-5-18-9-14(12)15/h1-6,8-10H,7H2,(H,20,21) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(2,6-naphthyridin-4-yl)acetamide |
|
| NUR | Name: | 2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-N-methylacetamide | Formula: | C18 H15 Cl N2 O | SMILES: | Clc1cccc(c1)CC(=O)N(C)c1cncc2ccccc21 | InChi: | InChI=1S/C18H15ClN2O/c1-21(18(22)10-13-5-4-7-15(19)9-13)17-12-20-11-14-6-2-3-8-16(14)17/h2-9,11-12H,10H2,1H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-N-methylacetamide |
|
| 54C | Name: | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan | Formula: | C16 H20 N2 O4 | SMILES: | C(C(=O)O)(N)C(c1cn(c2c1cccc2)C(C)(C)C3CO3)O | InChi: | InChI=1S/C16H20N2O4/c1-16(2,12-8-22-12)18-7-10(14(19)13(17)15(20)21)9-5-3-4-6-11(9)18/h3-7,12-14,19H,8,17H2,1-2H3,(H,20,21)/t12-,13-,14+/m0/s1 | Definition date: | 2015-07-23 | Last modified: | 2023-11-03 | Release date: | 2015-10-28 | Identifier: | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan |
|
| NV9 | Name: | 2-(3-chlorophenyl)-N-(4-phenylpyridin-3-yl)acetamide | Formula: | C19 H15 Cl N2 O | SMILES: | O=C(Nc1cnccc1c1ccccc1)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C19H15ClN2O/c20-16-8-4-5-14(11-16)12-19(23)22-18-13-21-10-9-17(18)15-6-2-1-3-7-15/h1-11,13H,12H2,(H,22,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(4-phenylpyridin-3-yl)acetamide |
|
| NVA | Name: | NORVALINE | Formula: | C5 H11 N O2 | SMILES: | O=C(O)C(N)CCC | InChi: | InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | L-norvaline |
|
| NVO | Name: | 2-(3-chlorophenyl)-N-(phthalazin-1-yl)acetamide | Formula: | C16 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1nncc2ccccc21 | InChi: | InChI=1S/C16H12ClN3O/c17-13-6-3-4-11(8-13)9-15(21)19-16-14-7-2-1-5-12(14)10-18-20-16/h1-8,10H,9H2,(H,19,20,21) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(phthalazin-1-yl)acetamide |
|
| NW0 | Name: | 3-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C15 H15 Cl N2 O | SMILES: | O=C(Nc1cnccc1C)CCc1cccc(Cl)c1 | InChi: | InChI=1S/C15H15ClN2O/c1-11-7-8-17-10-14(11)18-15(19)6-5-12-3-2-4-13(16)9-12/h2-4,7-10H,5-6H2,1H3,(H,18,19) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide |
|
| 55I | Name: | 4-(trifluoromethyl)-L-phenylalanine | Formula: | C10 H10 F3 N O2 | SMILES: | FC(F)(F)c1ccc(CC(N)C(=O)O)cc1 | InChi: | InChI=1S/C10H10F3NO2/c11-10(12,13)7-3-1-6(2-4-7)5-8(14)9(15)16/h1-4,8H,5,14H2,(H,15,16)/t8-/m0/s1 | Definition date: | 2021-07-16 | Last modified: | 2023-11-03 | Release date: | 2021-09-29 | Identifier: | 4-(trifluoromethyl)-L-phenylalanine |
|
| NWI | Name: | 2-(3-chlorophenyl)-N-(1,6-naphthyridin-8-yl)acetamide | Formula: | C16 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2cccnc21 | InChi: | InChI=1S/C16H12ClN3O/c17-13-5-1-3-11(7-13)8-15(21)20-14-10-18-9-12-4-2-6-19-16(12)14/h1-7,9-10H,8H2,(H,20,21) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1,6-naphthyridin-8-yl)acetamide |
|
| 562 | Name: | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine | Formula: | C12 H26 N7 O4 | SMILES: | NC(CCCNC(=N)NCCOCCOCCN=[N+]=N)C(=O)O | InChi: | InChI=1S/C12H25N7O4/c13-10(11(20)21)2-1-3-16-12(14)17-4-6-22-8-9-23-7-5-18-19-15/h10,15H,1-9,13H2,(H3-,14,16,17,20,21)/p+1/t10-/m0/s1 | Definition date: | 2015-07-31 | Last modified: | 2023-11-03 | Release date: | 2018-03-14 | Identifier: | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine |
|
| 56A | Name: | 3-(8-phenyloctyl)-L-histidine | Formula: | C20 H29 N3 O2 | SMILES: | O=C(O)C(N)Cc1cncn1CCCCCCCCc2ccccc2 | InChi: | InChI=1S/C20H29N3O2/c21-19(20(24)25)14-18-15-22-16-23(18)13-9-4-2-1-3-6-10-17-11-7-5-8-12-17/h5,7-8,11-12,15-16,19H,1-4,6,9-10,13-14,21H2,(H,24,25)/t19-/m0/s1 | Definition date: | 2011-04-29 | Last modified: | 2023-11-03 | Identifier: | 3-(8-phenyloctyl)-L-histidine |
|
| NX9 | Name: | 2-(3-chlorophenyl)-N-(1H-pyrazol-4-yl)acetamide | Formula: | C11 H10 Cl N3 O | SMILES: | O=C(Cc1cccc(Cl)c1)Nc1c[NH]nc1 | InChi: | InChI=1S/C11H10ClN3O/c12-9-3-1-2-8(4-9)5-11(16)15-10-6-13-14-7-10/h1-4,6-7H,5H2,(H,13,14)(H,15,16) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1H-pyrazol-4-yl)acetamide |
|